rs149988025

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1

The NM_006785.4(MALT1):​c.677A>G​(p.Lys226Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000779 in 1,596,824 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. K226K) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00092 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00076 ( 0 hom. )

Consequence

MALT1
NM_006785.4 missense

Scores

19

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.0450

Publications

6 publications found
Variant links:
Genes affected
MALT1 (HGNC:6819): (MALT1 paracaspase) This gene encodes a caspase-like protease that plays a role in BCL10-induced activation of NF-kappaB. The protein is a component of the CARMA1-BCL10-MALT1 (CBM) signalosome that triggers NF-kappaB signaling and lymphoctye activation following antigen-receptor stimulation. Mutations in this gene result in immunodeficiency 12 (IMD12). This gene has been found to be recurrently rearranged in chromosomal translocations with other genes in mucosa-associated lymphoid tissue lymphomas, including a t(11;18)(q21;q21) translocation with the baculoviral IAP repeat-containing protein 3 (also known as apoptosis inhibitor 2) locus [BIRC3(API2)-MALT1], and a t(14;18)(q32;q21) translocation with the immunoglobulin heavy chain locus (IGH-MALT1). Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, May 2018]
MALT1 Gene-Disease associations (from GenCC):
  • combined immunodeficiency due to MALT1 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0064280927).
BP6
Variant 18-58709405-A-G is Benign according to our data. Variant chr18-58709405-A-G is described in ClinVar as Likely_benign. ClinVar VariationId is 474599.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000919 (140/152294) while in subpopulation NFE AF = 0.00156 (106/68032). AF 95% confidence interval is 0.00132. There are 0 homozygotes in GnomAd4. There are 58 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MALT1NM_006785.4 linkc.677A>G p.Lys226Arg missense_variant Exon 5 of 17 ENST00000649217.2 NP_006776.1 Q9UDY8-1A8K5S1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MALT1ENST00000649217.2 linkc.677A>G p.Lys226Arg missense_variant Exon 5 of 17 NM_006785.4 ENSP00000497997.1 Q9UDY8-1

Frequencies

GnomAD3 genomes
AF:
0.000920
AC:
140
AN:
152176
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00346
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000660
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00156
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000764
AC:
184
AN:
240832
AF XY:
0.000691
show subpopulations
Gnomad AFR exome
AF:
0.000317
Gnomad AMR exome
AF:
0.000189
Gnomad ASJ exome
AF:
0.00317
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000419
Gnomad NFE exome
AF:
0.00119
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000764
AC:
1104
AN:
1444530
Hom.:
0
Cov.:
31
AF XY:
0.000825
AC XY:
592
AN XY:
717872
show subpopulations
African (AFR)
AF:
0.0000305
AC:
1
AN:
32762
American (AMR)
AF:
0.000167
AC:
7
AN:
41986
Ashkenazi Jewish (ASJ)
AF:
0.00355
AC:
91
AN:
25616
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39142
South Asian (SAS)
AF:
0.0000122
AC:
1
AN:
82262
European-Finnish (FIN)
AF:
0.000565
AC:
30
AN:
53076
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5712
European-Non Finnish (NFE)
AF:
0.000855
AC:
944
AN:
1104370
Other (OTH)
AF:
0.000503
AC:
30
AN:
59604
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
50
100
149
199
249
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000919
AC:
140
AN:
152294
Hom.:
0
Cov.:
33
AF XY:
0.000779
AC XY:
58
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.000241
AC:
10
AN:
41562
American (AMR)
AF:
0.000327
AC:
5
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00346
AC:
12
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.000660
AC:
7
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00156
AC:
106
AN:
68032
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00115
Hom.:
1
Bravo
AF:
0.000638
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00105
AC:
9
ExAC
AF:
0.000733
AC:
89
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MALT1: BP4 -

Combined immunodeficiency due to MALT1 deficiency Benign:1
Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.76
CADD
Benign
2.3
DANN
Benign
0.96
DEOGEN2
Benign
0.21
T;T;.
Eigen
Benign
-0.92
Eigen_PC
Benign
-0.82
FATHMM_MKL
Benign
0.062
N
LIST_S2
Benign
0.71
.;T;T
M_CAP
Benign
0.0024
T
MetaRNN
Benign
0.0064
T;T;T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
0.72
N;N;N
PhyloP100
0.045
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-0.37
N;.;N
REVEL
Benign
0.033
Sift
Benign
0.59
T;.;T
Sift4G
Benign
0.69
T;.;T
Polyphen
0.0
B;B;B
Vest4
0.094
MVP
0.23
MPC
0.41
ClinPred
0.0049
T
GERP RS
-0.93
Varity_R
0.095
gMVP
0.44
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.17
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149988025; hg19: chr18-56376637; COSMIC: COSV61934327; API